These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 38341859)
1. Pioglitazone attenuate level of myeloperoxidases and nitic oxide in psoriatic lesion: a proof-of-concept study in a imiquimod induced psoriasis model in rat. Chatterjee O; Sur D J Basic Clin Physiol Pharmacol; 2024 Jan; 35(1-2):45-52. PubMed ID: 38341859 [TBL] [Abstract][Full Text] [Related]
2. Molecular and histopathological profiling of imiquimod induced dermatosis in Swiss Wistar rats: contribution to the rat model for novel anti-psoriasis treatments. Smajlović A; Haverić A; Alić A; Hadžić M; Smajlović A; Mujezinović I; Lojo-Kadrić N; Ramić J; Elez-Burnjaković N; Haverić S; Pojskić L Mol Biol Rep; 2021 May; 48(5):4295-4303. PubMed ID: 34097205 [TBL] [Abstract][Full Text] [Related]
3. Development of a psoriatic-like skin inflammation rat model using imiquimod as an inducing agent. Parmar KM; Jagtap CS; Katare NT; Dhobi M; Prasad SK Indian J Pharmacol; 2021; 53(2):125-131. PubMed ID: 34100396 [TBL] [Abstract][Full Text] [Related]
4. Unconjugated bilirubin and its derivative ameliorate IMQ-induced psoriasis-like skin inflammation in mice by inhibiting MMP9 and MAPK pathway. Bharatha M; Nandana MB; Praveen R; Nayaka S; Velmurugan D; Vishwanath BS; Rajaiah R Int Immunopharmacol; 2024 Mar; 130():111679. PubMed ID: 38377853 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of Emami Z; Shobeiri SS; Khorrami R; Haghnavaz N; Rezaee MA; Moghadam M; Pordel S; Sankian M Mediators Inflamm; 2024; 2024():5821996. PubMed ID: 39045230 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of Clobetasol and Tacrolimus Treatments in an Imiquimod-Induced Psoriasis Rat Model. Guillaume P; Rupp T; Froget G; Goineau S Int J Mol Sci; 2024 Aug; 25(17):. PubMed ID: 39273201 [TBL] [Abstract][Full Text] [Related]
7. Anti-IL-17A ssDNA aptamer ameliorated psoriasis skin lesions in the imiquimod-induced psoriasis mouse model. Shobeiri SS; Rezaee M; Pordel S; Haghnnavaz N; Dashti M; Moghadam M; Sankian M Int Immunopharmacol; 2022 Sep; 110():108963. PubMed ID: 35724603 [TBL] [Abstract][Full Text] [Related]
8. Losartan ointment attenuates imiquimod-induced psoriasis-like inflammation. Shokrian Zeini M; Haddadi NS; Shayan M; Shokrian Zeini M; Kazemi K; Solaimanian S; Abdollahifar MA; Hedayatyanfard K; Dehpour AR Int Immunopharmacol; 2021 Nov; 100():108160. PubMed ID: 34583123 [TBL] [Abstract][Full Text] [Related]
9. Topical anti-TNF-a ssDNA aptamer decreased the imiquimod induced psoriatic inflammation in BALB/c mice. Shobeiri SS; Dashti M; Pordel S; Rezaee M; Haghnavaz N; Moghadam M; Ansari B; Sankian M Cytokine; 2023 Dec; 172():156406. PubMed ID: 37879125 [TBL] [Abstract][Full Text] [Related]
10. Daphnetin inhibits proliferation and inflammatory response in human HaCaT keratinocytes and ameliorates imiquimod-induced psoriasis-like skin lesion in mice. Gao J; Chen F; Fang H; Mi J; Qi Q; Yang M Biol Res; 2020 Oct; 53(1):48. PubMed ID: 33081840 [TBL] [Abstract][Full Text] [Related]
11. Therapeutic effects of the extract of Sancao Formula, a Chinese herbal compound, on imiquimod-induced psoriasis via cysteine-rich protein 61. Guo WJ; Wang Y; Deng Y; Cheng LY; Liu X; Xi RF; Zhu SJ; Feng XY; Hua L; Ze K; Zhu JY; Guo DJ; Li FL J Integr Med; 2022 Jul; 20(4):376-384. PubMed ID: 35491357 [TBL] [Abstract][Full Text] [Related]
12. Small interfering RNA targeting of keratin 17 reduces inflammation in imiquimod-induced psoriasis-like dermatitis. Xiao CY; Zhu ZL; Zhang C; Fu M; Qiao HJ; Wang G; Dang EL Chin Med J (Engl); 2020 Nov; 133(24):2910-2918. PubMed ID: 33237695 [TBL] [Abstract][Full Text] [Related]
13. Effect on ethanolic extract of sechiumedule fruitson imquimod-induced psoriasis like dermatitis in wistar rats. Sm F; Sarkar D; Samuel Kelechi M; AAl-Haidari R; N Al Busaidi H; Samman W; Alhaddad A; Ah Mostafa M Pak J Pharm Sci; 2022 Jul; 35(4):1083-1088. PubMed ID: 36008905 [TBL] [Abstract][Full Text] [Related]
14. Kan-Lu-Hsiao-Tu-Tan, a traditional Chinese medicine formula, inhibits human neutrophil activation and ameliorates imiquimod-induced psoriasis-like skin inflammation. Chiang CC; Cheng WJ; Lin CY; Lai KH; Ju SC; Lee C; Yang SH; Hwang TL J Ethnopharmacol; 2020 Jan; 246():112246. PubMed ID: 31539577 [TBL] [Abstract][Full Text] [Related]
15. Interleukin-18 exacerbates skin inflammation and affects microabscesses and scale formation in a mouse model of imiquimod-induced psoriasis. Niu XL; Huang Y; Gao YL; Sun YZ; Han Y; Chen HD; Gao XH; Qi RQ Chin Med J (Engl); 2019 Mar; 132(6):690-698. PubMed ID: 30741833 [TBL] [Abstract][Full Text] [Related]
16. Characterization and active component identification of Premna herbacea roxb. root extract reveals anti-inflammatory effect and amelioration of imiquimod induced psoriasis via modulation of macrophage inflammatory response. Sarkar D; Gorai P; Pramanik A; Mondal A; Mondal NK; Modak BK; Bhattacharyya S Phytomedicine; 2023 Oct; 119():155007. PubMed ID: 37549537 [TBL] [Abstract][Full Text] [Related]
17. Cudraxanthone D Ameliorates Psoriasis-like Skin Inflammation in an Imiquimod-Induced Mouse Model via Inhibiting the Inflammatory Signaling Pathways. Kim N; Lee S; Kang J; Choi YA; Jang YH; Jeong GS; Kim SH Molecules; 2021 Oct; 26(19):. PubMed ID: 34641629 [TBL] [Abstract][Full Text] [Related]
18. Pioglitazone, a peroxisome proliferator-activated receptor gamma ligand, suppresses bleomycin-induced acute lung injury and fibrosis. Aoki Y; Maeno T; Aoyagi K; Ueno M; Aoki F; Aoki N; Nakagawa J; Sando Y; Shimizu Y; Suga T; Arai M; Kurabayashi M Respiration; 2009; 77(3):311-9. PubMed ID: 18974632 [TBL] [Abstract][Full Text] [Related]
19. Comparison of normal versus imiquimod-induced psoriatic skin in mice for penetration of drugs and nanoparticles. Sun L; Liu Z; Lin Z; Cun D; Tong HH; Yan R; Wang R; Zheng Y Int J Nanomedicine; 2018; 13():5625-5635. PubMed ID: 30271151 [TBL] [Abstract][Full Text] [Related]
20. Yang BY; Cheng YG; Liu Y; Liu Y; Tan JY; Guan W; Guo S; Kuang HX Molecules; 2019 Jun; 24(11):. PubMed ID: 31181689 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]